[1]
J. L. Green, T. Dailey-Govoni, and S. K. Vosburg, “Opioid-related clinical outcomes and associated healthcare costs following abuse/misuse of oxycodone formulations: A HEOR analysis from real-world data”, J of Opioid Management, vol. 20, no. 4, pp. 281–288, Aug. 2024.